US OptionsDetailed Quotes
VIR241220P12500
- 2.85
- 0.000.00%
15min DelayClose Dec 20 16:00 ET
0.00High0.00Low
2.85Open2.85Pre Close0 Volume3 Open Interest12.50Strike Price0.00Turnover0.00%IV-31.47%PremiumDec 20, 2024Expiry Date5.16Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.22Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Vir Biotechnology Stock Discussion
Sign in to post a comment
NOTE: Whenever a stock is up, make sure you check its dilution risk - cash on hand because most likely if they are cash-strapped, they will make offering. Scaling out is key. NEVER listen to those who say hold on because if you lose money, they wouldnt care AT ALL.
*************************************
REVERSE...
*************************************
REVERSE...
60
8
$Vir Biotechnology (VIR.US)$ Reuters· 16:05
Vir Biotechnology Receives FDA Breakthrough Therapy Designation and EMA Prime Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta
Vir Biotechnology Receives FDA Breakthrough Therapy Designation and EMA Prime Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta
2
$Nauticus Robotics (KITT.US)$ $Kindly MD (KDLY.US)$ $Jayud Global Logistics Ltd. (JYD.US)$ $Mobilicom (MOB.US)$ $Vir Biotechnology (VIR.US)$ $Arqit Quantum (ARQQ.US)$ $Serina Therapeutics (SER.US)$ $Credo Technology (CRDO.US)$ $Citius Oncology (CTOR.US)$ $Shimmick (SHIM.US)$ $Janux Therapeutics (JANX.US)$ $Volato Group (SOAR.US)$ $Cheetah Net Supply Chain Service (CTNT.US)$
📊⚡️📊
📊⚡️📊
Note: This seems to be a long list. The rationale is that I al focused on at least 20% gains and not just after bangers. My trading style is to compound those 10-15-20-30% earnings and roll all profit rather than waiting for runners everyday. If runners appear, then I’ll grab it as well. Each has his own style earning.
$Damon Inc (DMN.US)$ Can be my PM gapper. Low float EV stock. IPO las...
$Damon Inc (DMN.US)$ Can be my PM gapper. Low float EV stock. IPO las...
35
19
5
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
$CytomX (CTMX.US)$ $Onconetix (ONCO.US)$ $Edesa Biotech (EDSA.US)$ $XBP Europe Holdings (XBP.US)$ $Nauticus Robotics (KITT.US)$ $Alset (AEI.US)$ $Carmell (CTCX.US)$ $Jayud Global Logistics Ltd. (JYD.US)$ $Vir Biotechnology (VIR.US)$ $Shimmick (SHIM.US)$ $Credo Technology (CRDO.US)$ $Janux Therapeutics (JANX.US)$ $Citius Oncology (CTOR.US)$ $Volato Group (SOAR.US)$
📊⚡️📊
📊⚡️📊
3
7
1
$Vir Biotechnology (VIR.US)$
Vir Biotechnology Presents Positive Chronic Hepatitis Delta Clinical Trial Data and Announces Initiation of Phase 3 Registrational Program
Phase 3 Eclipse Program to Evaluate Tobevibart and Elebsiran
Vir Biotechnology Presents Positive Chronic Hepatitis Delta Clinical Trial Data and Announces Initiation of Phase 3 Registrational Program
Phase 3 Eclipse Program to Evaluate Tobevibart and Elebsiran
$Vir Biotechnology (VIR.US)$ Reuters· just
Vir Biotechnology Receives Positive Opinion on Orphan Drug Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta From European Medicines Agency
Vir Biotechnology Receives Positive Opinion on Orphan Drug Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta From European Medicines Agency
1
2
No comment yet
Den the Dragon : Good
my friend
李飞Allyssa : Thank you for your daily dedication.
101726747 : ty
Den the Dragon : hit
Phuong999 : Thank you
View more comments...